Dopaminomimetic psychosis in Parkinson's disease: First symptom of early dementia?;Psicosis inducida por fármacos dopaminomiméticos en la enfermedad de Parkinson idiopática: ¿Primer síntoma de deterioro cognitivo?

Revista de Neurologia

Volumn 32, Issue 11, 2001, Pages 1085-1087

  Catalan Alonso Ma J ^a   Del Val, J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Dementia; Dopaminergic drugs; Parkinson's disease; Psychosis

Indexed keywords

AMANTADINE; APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LISURIDE; NEUROLEPTIC AGENT; OLANZAPINE; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE; RISPERIDONE; ROPINIROLE; SELEGILINE; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT;

CHOLINERGIC SYSTEM; CONFERENCE PAPER; DEMENTIA; DOPAMINERGIC SYSTEM; DRUG WITHDRAWAL; FRONTAL CORTEX; HUMAN; LIMBIC CORTEX; LONG TERM CARE; NEUROTRANSMISSION; PARKINSON DISEASE; PATHOGENESIS; PRACTICE GUIDELINE; PSYCHOSIS; SEROTONINERGIC SYSTEM; ARTICLE; PATHOPHYSIOLOGY;

ANTIPARKINSON AGENTS; DOPAMINE AGENTS; HUMANS; PARKINSON DISEASE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 0035376503     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3211.2000161     Document Type: Conference Paper

References (7)

1. Diagnostic criteria for Parkinson's disease
2. Prevalence and clinical correlates of psychosis in Parkinson's disease
3. Psychosis in Parkinson's disease
4. Fronto-subcortical circuits and human behavior
5. Psychotic complications of long-term levodopa therapy in Parkinson's disease
6. Psychosis in basal ganglia disorders: Epidemiology
7. The pharmacological treatment of dopaminomimetic psychosis